Lung Cancer Medical Reference

Learn about common and serious side effects of Jideytro (zidesamtinib), how to manage them, and potential drug interactions for ROS1-positive NSCLC treatment.

Discover the latest breakthroughs in EGFR-positive NSCLC treatment and how you can live better with lung cancer.

Learn how advance directives, living wills, and power of attorney help with end-of-life planning for metastatic small cell lung cancer.

Learn how your EGFR-positive lung cancer is different from other lung cancers and what it may mean for your treatment, prognosis, and more.

Learn more about research in EGFR-mutated NSCLC, new treatments in testing, and what you may expect to see over the course of your treatment journey.

Find out how lung cancer metastasis affects your brain, what to expect, and how your treatment could change.

A lung cancer diagnosis when you’ve never smoked can feel surprising. You likely have questions about what may have caused the illness.

How to organize important information for your loved ones after a lung cancer diagnosis.

If you’re over 65 and have NSCLC, you may wonder if and how your age may affect your treatment plan. Here’s how your age factors into your cancer care.

A guide to understanding your non-small-cell lung cancer (NSCLC) diagnosis, including a diagnosis and treatment timeline and your medical care team.

Learn how to navigate lung cancer costs, including insurance premiums, disability benefits, drug costs, and more with assistance programs and other tools.

Find out how lung cancer can impact your smell and taste. Get tips to manage the changes and boost appetite.

Learn about your risk for an EGFR mutation and how to explain your lung cancer risk to family.

Finding fun during lung cancer treatment can lower stress and boost your mood and immune system. Discover your fun with these tips.

If you have NSCLC, you may need some help. Sometimes, an adult child has to step in. Learn what happens when the parent-child roles are reversed.

Learn about biopsy, biomarkers, and which factors impact your non-small cell lung cancer treatment when you're 65 or older.

Find out which treatments are on the horizon for lung cancer and get the latest clinical trial trends.

Lung cancer can cause pain throughout your body. Learn what's behind the pain and which medications and therapies can help you feel better.

Lung adenocarcinoma is the most common lung cancer in the U.S. Find out who’s at risk, symptoms to watch for, and how to prevent complications.

Hyrnuo is a kinase inhibitor. Here’s how it treats lung cancer.

Zepzelca is a prescription chemotherapy medicine. Here’s how it treats small-cell lung cancer.

This guide to HER2-mutated non-small-cell lung cancer (NSCLC) explains the basics of the disease, including its causes, symptoms, diagnosis, treatment, and more.

Rybrevant and Rybrevant Faspro are targeted cancer medicines. Here's what to know.

Alunbrig is a tyrosine kinase inhibitor. Here’s how it treats ALK-positive non-small-cell lung cancer.

Palliative care can be just what you need for late-stage lung cancer.

Zykadia is a tyrosine kinase inhibitor. Here’s how it treats non-small-cell lung cancer.

Hernexeos is a targeted therapy. Here’s how it treats non-small-cell lung cancer (NSCLC).

Datroway is a prescription injection medicine. Here’s how it treats non-small-cell lung cancer (NSCLC).

Zegfrovy is a kinase inhibitor. Here’s how it treats non-small-cell lung cancer (NSCLC).

Ibtrozi is a kinase inhibitor. Here’s how it treats non-small-cell lung cancer.

Emrelis is a prescription injectable medicine. Here’s how it treats non-squamous non-small-cell lung cancer (NSCLC).

Ensacove is a kinase inhibitor. Here’s how it treats lung cancer.

Advances in NSCLC treatments, from machine learning and new medications, are offering new hope for patients. Learn about these emerging therapies.

Treating your NSCLC might include more than one type of treatment because combination therapy is better at controlling and managing this type of cancer.

Keytruda is a targeted therapy for cancer. Here’s how it treats lung cancer.

Learn about the role of EGFR mutations in NSCLC, how it is treated, and which groups are most at risk.

Libtayo is a monoclonal antibody. Here’s how it treats non-small-cell lung cancer.

Imfinzi is an immunotherapy. Here’s how it treats non-small-cell lung cancer.

Yervoy is an immune checkpoint inhibitor. Here’s how it treats lung cancer.

Alecensa is a kinase inhibitor. Here’s how it treats non-small-cell lung cancer.

Opdivo and Opdivo Qvantig are a type of immunotherapy. Here’s how they treat lung cancer.

Tagrisso is a kinase inhibitor. Here’s how it treats non-small cell lung cancer.

Retevmo is a targeted therapy. Here’s how it treats lung cancer.

If you have NSCLC, biomarker testing can help guide you and your care team to find the best treatment for you. Learn more about biomarker testing here.

Learn more about life planning with advanced NSCLC including how to plan for expenses, your care, life choices, and more.

Preparing yourself emotionally and logistically for the end of life.

Learn the causes, symptoms, and usual treatments for this most common type of lung cancer.

Your risk for the condition may be affected by gene mutations. Learn what causes them and how genes may affect cancer treatment.

NSCLC treatments are getting better. Learn how targeted therapy and immunotherapy can help your care team personalize your treatment for the best results.